J&J to sell sterilization unit to Fortive for $2.7 billion

J&J to sell sterilization unit to Fortive for $2.7 billion

(Reuters) - U.S. drug maker Johnson & Johnson said on Wednesday it received a binding cash offer of about $2.7 billion for its sterilization products business from Fortive Corp .

J&J's advanced sterilization products (ASP) business, part of its Ethicon Inc unit, generated revenue of about $775 million in 2017.

Fortive, a maker of industrial products, plans to finance the acquisition through debt or equity and with available cash and said it expected the acquisition to add to adjusted earnings in the first full year after the transaction.

Everett, Washington-based Fortive was spun-off in 2016 from Danaher Corp , which develops technology for dental, life sciences and diagnostics industries.

(Reporting by Tamara Mathias in Bengaluru; Editing by Anil D'Silva)

This story has not been edited by Firstpost staff and is generated by auto-feed.


Updated Date: Jun 07, 2018 03:05 AM

Also Watch

Social Media Star: Abhishek Bachchan, Varun Grover reveal how they handle selfies, trolls and broccoli
  • Monday, July 16, 2018 It's a Wrap: Soorma star Diljit Dosanjh and Hockey legend Sandeep Singh in conversation with Parul Sharma
  • Monday, July 16, 2018 Watch: Dalit man in Uttar Pradesh defies decades of prejudice by taking out baraat in Thakur-dominated Nizampur village
  • Monday, July 16, 2018 India's water crisis: After govt apathy, Odisha farmer carves out 3-km canal from hills to tackle scarcity in village
  • Sunday, July 15, 2018 Maurizio Sarri, named as new Chelsea manager, is owner Roman Abramovich's latest gamble in quest for 'perfect football'

Also See